Yoshida M, Noguchi E, Tsuru N, Ohkoshi N
Department of Neurology, Tsukuba College of Technology Kasuga 4-12-7, City of Tukuba, 305-0821, Ibaraki, Japan.
Epilepsy Res. 2001 Aug;46(2):101-9. doi: 10.1016/s0920-1211(01)00251-0.
Riluzole possesses various synaptic effects including an inhibitory action on glutamate release. The drug has been shown to inhibit kindled seizures, while its effect on the acquisition of kindling has not been reported. We investigated effects of riluzole on the kindling development in addition to effects on kindled seizures.
A bipolar electrode was implanted in the right amygdala of rats. Riluzole was injected intraperitoneally 30 min before kindling stimulation. To investigate effects of riluzole on the kindling development, rats were stimulated once daily for the drug session of 14 days at a current of 200 microA, 60 Hz, 1 ms for 2 s and thereafter stimulated without drugs (drug-free session) until completion of kindling. Seizure ranks and after discharge duration were observed every day. To investigate effects of riluzole on kindled seizures, fully-kindled rats were stimulated at the current of generalized seizure threshold (GST) before and after the administration of riluzole. Seizure ranks and after discharge duration were measured. GST after the treatment was also determined.
The number of stimuli required for the first appearance of stage five seizure was significantly larger in rats treated with 8 mg/kg of riluzole than in vehicle controls. Riluzole at a dose of 8 mg/kg significantly retarded the development of seizure stages in the drug session. By comparison, effects on the duration of after discharge was relatively mild, though significantly different from the vehicle control. Riluzole at a dose of either 4 or 8 mg/kg markedly inhibited behavioral seizures and reduced the duration of after discharge in kindled seizures provoked by GST. The drug also significantly increased GST at both doses, suggesting that the anticonvulsant effects were attributed to the increase in GST.
It was demonstrated that inhibitory effects of riluzole on both kindled seizures and the development of behavioral seizures in kindling acquisition with relatively mild correlation to afterdischarge duration. These effects might be attributed to inhibitory actions of riluzole on glutamate release and NMDA-receptor mediated events.
利鲁唑具有多种突触效应,包括对谷氨酸释放的抑制作用。该药物已被证明可抑制点燃性癫痫发作,但其对点燃形成的影响尚未见报道。我们研究了利鲁唑对点燃发展的影响以及对点燃性癫痫发作的影响。
将双极电极植入大鼠右侧杏仁核。在点燃刺激前30分钟腹腔注射利鲁唑。为研究利鲁唑对点燃发展的影响,在给药期的14天内,每天以200微安、60赫兹、1毫秒持续2秒的电流对大鼠进行一次刺激,之后在无药物情况下(无药期)继续刺激直至点燃完成。每天观察癫痫发作等级和发作后放电持续时间。为研究利鲁唑对点燃性癫痫发作的影响,在利鲁唑给药前后,以全身性癫痫发作阈值(GST)的电流刺激完全点燃的大鼠。测量癫痫发作等级和发作后放电持续时间。还测定了治疗后的GST。
用8毫克/千克利鲁唑治疗的大鼠首次出现五级癫痫发作所需的刺激次数明显多于溶剂对照组。8毫克/千克剂量的利鲁唑在给药期显著延缓了癫痫发作阶段的发展。相比之下,其对发作后放电持续时间的影响相对较轻,尽管与溶剂对照组有显著差异。4毫克/千克或8毫克/千克剂量的利鲁唑均显著抑制行为性癫痫发作,并缩短了由GST诱发的点燃性癫痫发作的发作后放电持续时间。该药物在两种剂量下还显著提高了GST,表明抗惊厥作用归因于GST的升高。
结果表明,利鲁唑对点燃性癫痫发作以及点燃形成过程中行为性癫痫发作的发展均有抑制作用,且与发作后放电持续时间的相关性相对较小。这些作用可能归因于利鲁唑对谷氨酸释放和NMDA受体介导事件的抑制作用。